5 Enquiries MPhil and PhD Programs lifspg@ust.hk T: (852) 2358 7255 (852) 2358 7300 (852) 2358 7333 MSc in Biotechnology mscbtec@ust.hk T: (852) 2358 8200 MSc in Drug Regulatory Affairs and Policy drap@ust.hk T: (852) 2358 5892 Master of Philosophy in Life Science The MPhil program aims to train qualified students by providing research training in major areas of life science. It enables students to acquire the knowledge, skills, and experience required for research. A candidate for an MPhil degree is expected to demonstrate knowledge in the discipline and to synthesize and create new knowledge, making a contribution to the field. Master of Science in Biotechnology The MSc program is designed to provide rigorous training to students for professional careers in the biotechnology and pharmaceutical industries. Since its inception in 1993, it has been widely recognized as a premier academic program by professional practitioners in relevant fields. The curriculum is continuously enriched with various basic and advanced biotechnological elements, including pharmaceutical, analytical, transgenic and recombinant technology, bioprocessing, business operations and management. All these elements are unique for preparing our students to become scientific research leaders with entrepreneurship in emerging bio-industrial areas. btec.hkust.edu.hk Doctor of Philosophy in Life Science The PhD program aims to cultivate doctoral graduates who are capable of the design, initiation and execution of original research, who can independently conduct advanced research projects, who possess both a broad knowledge of modern life science and an in-depth knowledge of specialized areas, and who can also contribute original knowledge to the field of life sciences by publishing their findings in peer-reviewed international journals. Research Postgraduate Programs Taught Postgraduate Programs PhD MPhil MSc MSc Master of Science in Drug Regulatory Affairs and Policy The MSc program is designed to train professionals in drug regulatory affairs and policy, which are critical areas for Hong Kong and Greater Bay Area development. A notable highlight in the HKSAR Policy Address 2023 is the establishment of Hong Kong Centre for Medical Products Regulation (CMPR). The HKCMPR will be dedicated to potential restructuring and strengthening of current regulatory and approval regimes for medicine, medical devices and medical technology, in order to accelerate the approving applications and launching for registration of pharmaceutical products to the market. Our program is unique for preparing students to become proficient managers and main practitioners of guidance documents, laws, and regulations for pharmaceutical companies and government agencies. Upon completion of this program, graduates will be well-equipped to assume regulatory affairs positions in pharmaceutical, biotechnology, medical device, diagnostic and healthcare products companies, as well as government agencies. drap.hkust.edu.hk
RkJQdWJsaXNoZXIy NDk5Njg=